Compare iShares Core MSCI EAFE ETF (IEFA) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Mesoblast Limited — how do they compare? iShares Core MSCI EAFE ETF trades at $96.91, while Mesoblast Limited trades at $16.38 (market cap $2.17B). The key difference: iShares Core MSCI EAFE ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| IEFA | MESO | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $98.56 | $20.96 |
52-Week Low | $81.70 | $12.88 |
Market Cap | — | $2.17B |
Enterprise Value | — | $2.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
